Authors:
Marco, F
Bureo, E
Ortega, JJ
Badell, I
Verdaguer, A
Martinez, A
Munoz, A
Madero, L
Olive, T
Cubells, J
Castel, V
Sastre, A
Maldonado, MS
Diaz, MA
Citation: F. Marco et al., High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support, J CL ONCOL, 18(18), 2000, pp. 3256-3261
Authors:
Sole, F
Espinet, B
Sanz, GF
Cervera, J
Calasanz, MJ
Luno, E
Prieto, F
Granada, I
Hernandez, JM
Cigudosa, JC
Diez, JL
Bureo, E
Marques, ML
Arranz, E
Rios, R
Climent, JAM
Vallespi, T
Florensa, L
Woessner, S
Citation: F. Sole et al., Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes, BR J HAEM, 108(2), 2000, pp. 346-356
Authors:
Marco, F
Bureo, E
Delgado, MD
Richard, C
Cuadrado, MA
Retortillo, JAP
Recio, M
Zubizarreta, A
Citation: F. Marco et al., Translocation (10;11)(p13;p15) in an infant acute myeloid leukemia with MLL gene rearrangement, CANC GENET, 114(1), 1999, pp. 68-70
Authors:
Zarza, R
Pujades, A
Garcia, J
Alvarez, R
Carrera, A
Estella, J
Morey, M
Remacha, A
Perez-Lungmus, G
Nomdedeu, B
Sanchez, J
Gastearena, J
Bureo, E
Corrons, JLV
Citation: R. Zarza et al., Molecular study of red cell pyruvate-kinase deficiency in 15 patients withchronic haemolytic anaemia, MED CLIN, 112(16), 1999, pp. 606-609
Authors:
Munoz, A
Bureo, E
Ortega, JJ
Richard, C
Olive, T
Maldonado, MS
Madero, L
Diaz, MA
Citation: A. Munoz et al., Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy, HAEMATOLOG, 83(11), 1998, pp. 981-984